Twist Bioscience Corp’s filing revealed that its Chief Financial Officer Laponis Adam unloaded Company’s shares for reported $96545.0 on Jan 09 ’26. In the deal valued at $35.26 per share,2,738 shares were sold. As a result of this transaction, Laponis Adam now holds 140,031 shares worth roughly $5.63 million.
Then, Finn Patrick John bought 23,279 shares, generating $931,160 in total proceeds.
Before that, Laponis Adam bought 3,000 shares. Twist Bioscience Corp shares valued at $120,000 were divested by the Officer at a price of $40.00 per share.
Stephens initiated its Twist Bioscience Corp [TWST] rating to an Overweight in a research note published on November 04, 2025; the price target was $41. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. Guggenheim began covering TWST with “Buy” recommendation on June 04, 2024. Goldman revised its rating on January 17, 2024. It rated TWST as “a Buy” which previously was an “a Neutral”.
Price Performance Review of TWST
On Tuesday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 5.73% to $40.22. Over the last five days, the stock has gained 9.09%. Twist Bioscience Corp shares have fallen nearly -7.75% since the year began. Nevertheless, the stocks have risen 26.80% over the past one year.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-12-31, growing by 1.51 million shares to a total of 14.26 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 12.75 million shares. There was a rise of 10.57%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 27, 2023 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $27 price target.
